研究精神病中皮质谷氨酸和GABA功能的干扰及其起源和后果
Bill Deakin1, Elizabeth Liddle2, Mohanbabu Rathnaiah2
1Division of Psychology and Mental Health, University of Manchester, Manchester Academic Health Sciences Centre, M13 9PT, Manchester, UK. bill.deakin@manchester.ac.uk.
Molecular psychiatry
|November 18, 2025
概括
精神分裂症是一种精神分裂症.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 神经成像是一种神经成像.
背景情况:
- 精神分裂症的精神病症状可能源于早期的谷氨酸神经毒性,导致以后的突触损失.
- 磁共振光谱 (MRS) 显示,在精神分裂症患者中,尤其是老年患者中,谷氨酸减少.
研究的目的:
- 测试背前环状皮层 (dACC) 谷氨酸是否在最近出现的精神分裂症和已确定的精神分裂症之间有所不同.
- 为了研究潜在的机制:减少GABA,氧化应激和炎症.
主要方法:
- 一项3中心的MRS研究比较了dACC和脑后皮层中的谷氨酸和GABA.
- 测量了谷氨水平 (炎症标志物) 和循环中的细胞因子.
- 研究了MRS数据,细胞因子和临床症状之间的关联.
主要成果:
- 已确定的精神分裂症患者比最近出现的患者有更大的dACC谷氨酸缺乏症.
- 这种缺陷并不能通过抗精神病药物暴露,CRP,IL-6或谷氨酸水平来解释.
- 与对照组相比,GABA在dACC和脑后皮层中的患者减少.
- 较低的DACC GABA与增加的积极和消极症状相关.
结论:
- 在已确定的精神分裂症中,较大的dACC谷氨酸缺乏症表明晚期的突触损失,而不是早期的兴奋毒性.
- 减少DACC中的GABA与精神病的严重程度有关,支持其病理生理学作用.
- 作为主要驱动因素的炎症或氧化应激的证据有限.
相关概念视频
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
1.8K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.8K
01:28Psychosis and Antipsychotic Drugs: Overview
786
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
786
01:29Biological Causes of Schizophrenia
468
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
468
01:29Psychological and Sociocultural Causes of Schizophrenia
454
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
454
01:26Psychosis: Goals of Pharmacotherapy
449
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
449
01:14Antiepileptic Drugs: Glutamate Antagonists
865
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
865